The evolution of the CDM Roles according to the latest SCDM Reflection Paper on our journey towards Clinical Data Science.
Date: December 3, 2020
Time:11:00 AM - 12:30 PM EST
OVERVIEWThis webinar will dive into the latest SCDM Reflection Paper on the evolution of the CDM Roles as we embark on our journey towards Clinical Data Science.
The main objective of the webinar is to provide insights on how CDM professionals who have successfully and passionately contributed to the credibility of Clinical Data Management can evolve their skillsets and competencies to cope with the increasing complexities of clinical research. This demands novel risk-based approaches maximizing the potential of available technologies.
WHAT YOU'LL LEARN
- Understand trends leading to the evolution of the CDM Roles
- Understand what is required to succeed within a risk-based CDM Framework
- Explore advanced Clinical Data Science competencies which will drive future career opportunities
WHO SHOULD ATTENDThe evolution of the CDM Roles according to the latest SCDM Reflection Paper on our journey towards Clinical Data Science.
WHAT ARE THE BENEFITSAppreciate the potential professional opportunities offered by our evolution toward Clinical Data Science. .
MEET THE PRESENTERSPatrick Nadolny, Former Associate Vice President, Clinical Data Management and Programming Chair of SCDM Innovation Committee Clinical Data Science advisor to the SCDM Board
Mr. Nadolny has 28 years of industry experience across pharmaceutical, device and biologics as well as technology solution development. Mr. Nadolny is a pragmatic leader focusing on technology, innovation, strategic planning, change management, and the setup of new capabilities. Mr. Nadolny was the Global head of Clinical Data Management and Programming at Allergan (an Abbvie company). He supports SCDM thought leadership through the SCDM innovation committee which released reflection papers on the evolution of Clinical Data Management toward Clinical Data Science.
Ian Shafer, Partner in PwC’s Pharmaceutical Advisory Practice
Mr. Shafer is a and has been working in the BioPharmaceutical industry focused on Clinical Development for the past eighteen years. Ian joined PwC in 2019 and is focusing on global clinical development business transformation enabled by digital technologies. Previous to PwC, Ian led the Clinical Domain within Accenture's R&D practice, was one of the initial Medidata employees, and held multiple roles within Amgen's clinical development organization.
Ian’s project experience includes business strategy/roadmap development, operating model design, business case development, global digital business transformation, technology selection and implementation, emerging technologies and advanced analytics, business process optimization, change management, and SDLC management. Ian’s functional focus spanned program/protocol design, study start-up, clinical trial operations, data management, analysis and reporting, and submissions and has led 50+ major transformational programs during his career.
Ian received bachelors in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz in 1999.
Nechama Katan, Director, Data Science, Pfizer
Nechama Katan is a “Data Wizard with Personality.” She helps organizations access and use their data to drive business decisions. Nechama blends an ability to write code and provide prototypes with an interest in driving the “business conversation." In addition to working with various organizations, she is an experienced instructor in Statistics, Operations, Data presentation and Metrics development. Her education includes an MSc from NYU in Mathematics and an MA from Columbia University in Statistics. Nechama has worked in both startups, as a small business owner and more recently fortune 500 companies. Her experience spans high tech, low tech, health care, medical devices, finance and pharmaceuticals.
EARN CEUsParticipants are eligible to receive CEUs upon attendance and successful completion of a web-based assessment within 30 days after the webinar. CEUs are not granted after the 30-day assessment deadline.
SCDM is authorized by IACET to offer 0.2 CEUs for this program.
|Group (max. 10 ppl.)||$960||$1,140|
Group Registration Policy: Any group registration allows up to 10 people to attend the webinar and to complete the webinar assessment. Credits will be granted on an individual basis upon successful completion of the assessment by the registered participants.
Refund Policy: Participants will receive a full refund if notice is provided in writing via post or email one week prior to the webinar date. If cancellation occurs within the week prior the webinar, participants will be allowed to apply 50% of the webinar fee to the next offering of the same webinar. No refunds will be offered after that time.
Click on the help button on the bottom right, select contact support and email the BlueSky team with any technical issues.
Otherwise e-mail directly to firstname.lastname@example.org or call +1-888-705-6002 for immediate help.
The SCDM Learning team is here to help. Contact us at email@example.com or call +32 232 024 87